Site Map
Search
Site Outline
Home
Company
Technology
Products
Investor Relations / Media
Contact Us
Feb. 28, 2008
Nanosphere Announces Fourth Quarter and 2007 Results; Customer Adoptions Validate Verigene
®
System(R) Advantages
Mar. 30, 2008
Nanosphere, Inc at American College of Cardiology (ACC) Scientific Sessions
Apr. 1, 2008
Nanosphere Satellite Symposium: The Clinical Utility of Highly Sensitive cTnI Assays
- Choose Product -
Verigene
®
System
Overview of the Verigene
®
Reader
Overview of the Verigene
®
Processor
Overview of a Verigene
®
Test Cartridge
Overview of the Verigene
®
System Workflow
Verigene
®
Nucleic Acid Tests
Genetics
Verigene
®
F5
Nucleic Acid Test (IVD)
Verigene
®
F2
Nucleic Acid Test (IVD)
Verigene
®
MTHFR
Nucleic Acid Test (IVD)
Verigene
®
CFTR
Nucleic Acid Test
Pharmacogenetics
Verigene
®
Warfarin Metabolism Nucleic Acid Test (IVD)
Infectious diseases
Oncology
Overview of the Verigene
®
Reader
Overview of the Verigene
®
Processor
Overview of a Verigene
®
Test Cartridge
Verigene
®
Test Cartridge
Genetics
Pharmacogenetics
Direct Detection of Nucleic Acids
Ultrasensitive Protein Detection
- Choose Job -
Process R and D Scientist
Facilities Manager
Research Assistant
Process Development Engineer
